ID   PC-5 [Human prostate carcinoma]
AC   CVCL_M124
DR   cancercelllines; CVCL_M124
DR   Wikidata; Q54938458
RX   PubMed=8200854;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI:27899; Cisplatin (CDDP).
CC   Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 05-10-23; Version: 15
//
RX   PubMed=8200854; DOI=10.1111/j.1349-7006.1994.tb02376.x;
RA   Fujii R.-i., Mutoh M., Niwa K., Yamada K., Aikou T., Nakagawa M.,
RA   Kuwano M., Akiyama S.-i.;
RT   "Active efflux system for cisplatin in cisplatin-resistant human KB
RT   cells.";
RL   Jpn. J. Cancer Res. 85:426-433(1994).
//